Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has CE-Marked Mologic Ltd’s (‘Mologic’) lateral flow antibody test for COVID-19 for
Omega Diagnostics Gp (ODX.L) WHO Prequalification received
VISITECT® CD4 Advanced Disease test receives WHO Prequalification
Omega Diagnostics Gp (ODX.L) Update on progress of UK-Rapid Test Consortium
CE Marking of COVID-19 lateral flow antibody test for professional use
Omega Diagnostics Gp (ODX.L) CE-Mark of COVID-19 ELISA antibody test
Colin King, CEO of Omega commented: “We are pleased that Omega has been able to CE-Mark Mologic’s ELISA antibody test and it is testimony to the teams within both companies